ライフサイエンスコーパス: minimal clinically important difference

1 he associated benefits were smaller than the minimal clinically important difference.

2 nd evaluated for availability of a published minimal clinically important difference.

3 Neither measure met the prespecified minimal clinically important difference.

4 status, and a change of >/=4 was deemed the minimal clinically important difference.

5 (HADS; score range, 0 [best] to 42 [worst]; minimal clinically important difference, 1.5) obtained d

6 [not affected] to 6 [as bad as it could be]; minimal clinically important difference, 1.66 units).

7 inician Rated (QIDS-C16) (score range, 0-27; minimal clinically important difference, 2 points).

8 moderately bad or worse cough (0 to 28 days; minimal clinically important difference, 3.79 days) and

9 rected age (standardized mean, 100 [SD, 15]; minimal clinically important difference, 5 points).

10 0; higher ratings indicate lower impairment; minimal clinically important difference, 5 score points]

11 In uncontrolled patients, ESS resulted in a minimal clinically important difference 57% of the time

12 nge of change in letters read, -121 to +101; minimal clinically important difference, 7 letters), ana

13 Seven of these had published minimal clinically important differences and were recomm

14 p < 0.001), higher likelihood of reporting a minimal clinically important difference (aPR = 1.42; 95%

15 verity; reduction of 10 or more considered a minimal clinically important difference) at baseline and

16 The minimal clinically important difference between groups w

17 A minimal clinically important difference cutoff determine

18 post-treatment (P = .005), exceeding the 0.5 minimal clinically important difference for FAQLQ-PF.

19 Estimates of the minimal clinically important difference for the 6-minute

20 ontinued to increase to 6 months, reaching a minimal clinically important difference for this scale.

21 her scores indicating worse quality of life; minimal clinically important difference >/=8.90), sense

22 est and 100 being the worst quality of life; minimal clinically important difference, >/=4), morbidit

23 A minimal clinically important difference has been establi

24 Minimal clinically important differences have not been e

25 Asthma Control Questionnaire 5 (in which the minimal clinically important difference is 0.5 points).

26 As of yet, its sensitivity to change and minimal clinically important difference (MCID) have not

27 The concept of a minimal clinically important difference (MCID) is well e

28 e responsiveness to change and determine the minimal clinically important difference (MCID) of the PO

29 (synonymous with sensitivity to change) and minimal clinically important difference (MCID) should be

30 To assess the reliability and the minimal clinically important differences (MCID) for FVC%

31 ary outcomes were change in WMFT time score (minimal clinically important difference [MCID] = 19 seco

32 le, 0 [no pain] to 10 [worst pain possible]; minimal clinically important difference [MCID], 1.8 unit

33 alk distance between baseline and 12 months (minimal clinically important difference [MCID], 25 m).

34 -Pal) instrument (range, 0-184 [worst-best]; minimal clinically important difference [MCID], 9 points

35 quantitative evaluation of cartilage volume (minimal clinically important difference not yet defined)

36 ercentage of participants with more than the minimal clinically important difference of -4 units was

37 nges from 0 (worst) to 100 (best), and has a minimal clinically important difference of 23 points.

38 Sample size was based on a minimal clinically important difference of 5 points for

39 ranges from 0 (worst) to 48 (best) and has a minimal clinically important difference of 5 points; and

40 nths was the primary outcome measure, with a minimal clinically important difference of 8 points.

41 advantages include the determination of the minimal clinically important difference of Child Health

42 The minimal clinically important difference on the global de

43 ent, psychometric properties, and ability of minimal clinically important difference to capture gains

44 The prespecified minimal clinically important difference was defined as 2

45 The minimal clinically important difference was defined as a